Skip to main content
logo
PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
5.20
+0.46 (9.70%)
At close: Aug 14, 2026, 4:00 PM EDT
5.27
+0.07 (1.35%)
After-hours: Aug 14, 2026, 7:34 PM EDT

PAVmed Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.110.0732.450.380.5
Revenue Growth
-89.02%-97.63%22.14%550.40%-24.60%-
Gross Profit
-0.25-0.15-1.85-3.97-3.24-0.09
Operating Income
-26.7-21.81-44.49-68.8-91.09-54.39
Net Income
-10.46-3.7731.97-66.27-89.26-50.63
Earnings Per Share
-9.86-5.6314.90-274.92-450.95-293.92
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.781.951.5322.3142.7579.25
Total Debt
17.0713.3531.8648.7336.64-
Net Cash (Debt)
-13.28-11.4-30.33-26.416.1179.25
Net Cash Growth
-----92.29%2998.01%
Net Cash Per Share
-5.60-17.00-13.95-109.5830.88460.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.73-5.21-33.55-52.04-70.99-40.59
Capital Expenditures
-0.05-0.03-0.06-0.24-1.54-1.47
Free Cash Flow
-7.78-5.24-33.61-52.28-72.53-42.06
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-220.54%-207.04%-61.60%-161.83%--17.00%
Operating Margin
-23841.96%-30712.68%-1485.38%-2805.67%-24161.01%-10878.60%
Pretax Margin
-14670.54%-3477.46%949.15%-3232.59%-27384.08%-11225.20%
Profit Margin
-9341.96%-5315.49%1067.31%-2702.69%-23677.45%-10126.00%
FCF Margin
-6948.21%-7376.06%-1122.17%-2132.06%-19237.40%-8412.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.22---
PS Ratio
332.3885.952.3213.53119.31432.64